Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

23,828 signal articles · 377 in last 24h · 113,331 total before filter · latest 55m ago
377last 24h
2063last 7d
343● bullish (7d)
181● bearish (7d)
204publishers
AllMacro323Earnings1116M&A94Regulatory24Product17Analyst22
✕ clear all filtersticker: ^GSPCSentiment:bullishneutralbearishshow all (incl. clickbait)
Ingredion (INGR): Buy, Sell, or Hold Post Q1 Earnings?
StockStory50d agoneutral
Ingredion (INGR): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, Ingredion’s stock price fell to $96.75. Shareholders have lost 12.9% of their capital, which is disappointing considering the S&P 500 has climbed by 7.8%. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

AI Concerns Hurt ServiceNow (NOW) Despite Strong Earnings
Insider Monkey50d agoneutral
AI Concerns Hurt ServiceNow (NOW) Despite Strong Earnings

Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned -10.6% in Q1 2026, significantly lagging the S&P 500’s -4.3% returns. The letter noted the quarter as the worst for equities since 2022, with strong corporate earnings being […]

Inspired (INSE): Buy, Sell, or Hold Post Q1 Earnings?
StockStory51d agoneutral
Inspired (INSE): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, Inspired’s stock price fell to $7.76. Shareholders have lost 15.6% of their capital, which is disappointing considering the S&P 500 has climbed by 8.5%. This might have investors contemplating their next move.

Harley-Davidson (HOG): Buy, Sell, or Hold Post Q1 Earnings?
StockStory51d agoneutral
Harley-Davidson (HOG): Buy, Sell, or Hold Post Q1 Earnings?

Harley-Davidson’s 19.5% return over the past six months has outpaced the S&P 500 by 11%, and its stock price has climbed to $24.78 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Hillman (HLMN): Buy, Sell, or Hold Post Q1 Earnings?
StockStory52d agoneutral
Hillman (HLMN): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, Hillman’s stock price fell to $8.22. Shareholders have lost 9.8% of their capital, which is disappointing considering the S&P 500 has climbed by 9%. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

Dick's (DKS): Buy, Sell, or Hold Post Q1 Earnings?
StockStory56d agoneutral
Dick's (DKS): Buy, Sell, or Hold Post Q1 Earnings?

Dick's has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 6.8% to $224.38 per share while the index has gained 10.9%.

Making Sense of the Evolving Earnings Picture
Zacks56d agoneutral
Making Sense of the Evolving Earnings Picture

Even when excluding the significant upward revisions to Energy sector estimates, aggregate Q2 earnings estimates for the remainder of the S&P 500 index would still be in positive territory since the start of April.

MillerKnoll (MLKN): Buy, Sell, or Hold Post Q1 Earnings?
StockStory57d agoneutral
MillerKnoll (MLKN): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, MillerKnoll’s shares (currently trading at $15.72) have posted a disappointing 10.4% loss, well below the S&P 500’s 12.4% gain. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

IQVIA (IQV): Buy, Sell, or Hold Post Q1 Earnings?
StockStory57d agoneutral
IQVIA (IQV): Buy, Sell, or Hold Post Q1 Earnings?

Over the last six months, IQVIA’s shares have sunk to $177.52, producing a disappointing 19.8% loss - a stark contrast to the S&P 500’s 12.4% gain. This might have investors contemplating their next move.

CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings?
StockStory62d agoneutral
CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, CVS Health has been a great trade, beating the S&P 500 by 20%. Its stock price has climbed to $100.39, representing a healthy 26.4% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Cal-Maine (CALM): Buy, Sell, or Hold Post Q1 Earnings?
StockStory63d agoneutral
Cal-Maine (CALM): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, Cal-Maine’s stock price fell to $79.32. Shareholders have lost 9.4% of their capital, which is disappointing considering the S&P 500 has climbed by 6.9%. This might have investors contemplating their next move.